133 related articles for article (PubMed ID: 22673025)
1. The growing importance of PON1 in cardiovascular health: a review.
Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE
J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025
[TBL] [Abstract][Full Text] [Related]
2. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.
van Himbergen TM; van Tits LJ; Roest M; Stalenhoef AF
Neth J Med; 2006 Feb; 64(2):34-8. PubMed ID: 16517986
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
Otocka-Kmiecik A; Orłowska-Majdak M
Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
Connelly PW; Draganov D; Maguire GF
Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
[TBL] [Abstract][Full Text] [Related]
5. [Paraoxonase: its multiple functions and pharmacological regulation].
Fridman O; Fuchs AG; Porcile R; Morales AV; Gariglio LO
Arch Cardiol Mex; 2011; 81(3):251-60. PubMed ID: 21975240
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of paraoxonases: a brief review.
Draganov DI; La Du BN
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013
[TBL] [Abstract][Full Text] [Related]
7. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases.
Androutsopoulos VP; Kanavouras K; Tsatsakis AM
Toxicol Appl Pharmacol; 2011 Nov; 256(3):418-24. PubMed ID: 21864557
[TBL] [Abstract][Full Text] [Related]
8. The paraoxonase gene family and atherosclerosis.
Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST
Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonases role in the prevention of cardiovascular diseases.
Rosenblat M; Aviram M
Biofactors; 2009; 35(1):98-104. PubMed ID: 19319852
[TBL] [Abstract][Full Text] [Related]
10. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
11. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
Deakin SP; James RW
Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
[TBL] [Abstract][Full Text] [Related]
12. Methylmercury-induced inhibition of paraoxonase-1 (PON1)-implications for cardiovascular risk.
Ginsberg G; Sonawane B; Nath R; Lewandowski P
J Toxicol Environ Health A; 2014; 77(17):1004-23. PubMed ID: 25072822
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase and atherosclerosis-related cardiovascular diseases.
Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
[TBL] [Abstract][Full Text] [Related]
14. The paraoxonases: role in human diseases and methodological difficulties in measurement.
Camps J; Marsillach J; Joven J
Crit Rev Clin Lab Sci; 2009; 46(2):83-106. PubMed ID: 19255916
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
Kim DS; Marsillach J; Furlong CE; Jarvik GP
Pharmacogenomics; 2013 Sep; 14(12):1495-515. PubMed ID: 24024900
[TBL] [Abstract][Full Text] [Related]
16. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
17. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
18. A long and winding road: defining the biological role and clinical importance of paraoxonases.
James RW
Clin Chem Lab Med; 2006; 44(9):1052-9. PubMed ID: 16958594
[TBL] [Abstract][Full Text] [Related]
19. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
20. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
